Search Results - "metastasis"
Suggested Topics within your search.
Suggested Topics within your search.
- therapy
- Neoplasms 6
- Cancer 3
- Colorectal Neoplasms 3
- Diagnostic Imaging 3
- Disease Management 3
- Head 3
- Head and Neck Neoplasms 3
- Lymph Nodes 3
- Lymphatic Metastasis 3
- Mouth 3
- Mouth Neoplasms 3
- Neck 3
- Neck Dissection 3
- Neovascularization, Physiologic 3
- Sentinel Lymph Node Biopsy 3
- Vascular Endothelial Growth Factors 3
- complications 3
- diagnosis 3
- diagnostic imaging 3
- drug therapy 3
- pathology 3
-
1
Management of the N0 neck
Published 2017Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
Get full text
Series
Electronic Video -
2
Management of the N0 neck
Published 2017Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
Get full text
Series
Electronic Video -
3
Management of the N0 neck
Published 2017Table of Contents: “…Contents: Patterns of spread of oral cancer -- Prognosis with metastatic neck disease -- Risk of occult metastasis -- Predictors of metastasis -- Tumour depth -- Perineural invasion -- Imaging of the node negative neck -- Sentinel lymph node biopsy -- Survival benefits of neck dissection.…”
Get full text
Series
Electronic Video -
4
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
5
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
6
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
7
Clinical applications of molecular imaging imaging to guide cancer therapy /
Published 2010Table of Contents: “…Contents: Anatomic vs. functional imaging -- Functional imaging modalities -- PET/CT -- Radiotracer imaging -- Existing cancer imaging paradigm -- A new paradigm for cancer imaging -- Imaging and targeted therapy -- Biomarker imaging -- ER expression and breast cancer endocrine therapy -- Hypoxia-specific treatment -- Biologic events in response to successful cancer therapy -- Thymidine incorporation pathways -- Bone metastasis response monitoring -- FDG PET vs. bone scan -- Neo-adjuvant therapy of breast cancer -- Molecular imaging is a tool for measuring in vivo biology -- Changes in breast cancer metabolism and blood flow predict pathologic response -- Clinical trial of novel molecular imaging probes for cancer -- ACRIN experimental imaging sciences committee.…”
Get full text
Series
Electronic Video -
8
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video -
9
Changing paradigms in anticancer drug development inhibiting angiogenesis in colorectal cancer /
Published 2009Table of Contents: “…Contents: Targeted therapy for cancer -- Angiogenesis is involved throughout tumour formation, growth and metastasis -- VEGF: molecular characteristics -- VEGF and other signals promote the angiogenic switch in tumours -- Tumour vasculature is abnormal -- VEGF produces immature tortuous vessels dependent on VEGF for survival -- Other features make VEGF an attractive target for anticancer therapy -- RhuMAb VEGF (bevacizumab/Avastin®) -- Significant reduction in microvasculature -- Anti-VEGF antibody improves drug delivery -- Avastin: an anti-VEGF agent for cancer therapy -- Use of Avastin with oxaliplatin-based therapy -- Addition of Avastin to oxaliplatin-based chemotherapy improved best confirmed response -- Study schema and organization.…”
Get full text
Series
Electronic Video